The Keri Lab focuses on molecularly understanding genomic instability, epigenetic regulation, and mechanisms governing therapeutic efficacy and resistance, all in the context of breast cancer.
The Keri Lab resides in the Lerner Research Institute at the Cleveland Clinic. Our mission is to provide key research findings in breast cancer to improve outcomes from this disease and to train the next generation of scientists. We provide care for each other and are fortunate to collaborate with other labs regionally, nationally, and internationally.
Our research is driven by curiosity. This curiosity has allowed us to be open to various biological fields in understanding breast cancer. Traditionally, we are known for investigating the roles of essential transcription factors in mammary gland development and carcinogenesis. Throughout the years we have expanded to investigating drug cocktails for treating breast cancer, elucidating mechanisms of therapeutic resistance, studying genomic instability, and understanding epigenetic regulation in breast cancer.
Contact Us
Postdoctoral researchers: We are hiring eligible postdocs! Send Dr. Keri a copy of your CV.
Graduate students: Interested in rotating in our lab? Use the form to tell us about your prior experience and research interests!
College and High School students: Considering a future in scientific research and want some experience? Fill out the form and let us know!